A Spokane resident, 34, was found guilty by a federal jury on March 25, 2026, for orchestrating an interstate drug trafficking operation that introduced fentanyl into Skagway, Alaska, resulting in two fatal overdoses. The verdict followed a five-day trial held in Juneau.
The case, prosecuted by the U.S. Attorney’s Office for the District of Alaska, centered on a scheme driven by significant price disparities in the illicit drug market. Between January 1 and January 13, 2023, the defendant agreed to purchase and mail roughly 150 fentanyl pills to a co-conspirator in the coastal Alaskan town.
The conspirators intended to capitalize on lower drug prices in Eastern Washington. The plan involved acquiring the synthetic opioids in Spokane and shipping them north to sell at a substantial markup in Skagway, with both parties sharing the profits.
Prosecutors highlighted that Skagway was a "dry" community at the time of the transaction, meaning fentanyl was not previously available locally. The arrival of the mailed package abruptly changed that dynamic. The sudden influx of the 150 pills led directly to the deaths of two men in the municipality.
The conviction underscores a broader pattern in which traffickers utilize Washington state as a staging area for distributing cheap synthetic opioids to isolated communities in Alaska and the Pacific Northwest.